Most Recent
US lab products giant Beckman Coulter has successfully opposed an Australian biotech's bid to trade mark ‘Cytophex’ for its stem cell expansion system, with an IP Australia delegate finding the mark is too similar to Beckman's ‘CytoFLEX’ mark.
Construction PRO
The ACT government’s has appointed Multiplex to support design and planning work for the next stage of the territory's northside hospital project in Canberra.
A group member in a class action against Johnson & Johnson unit DePuy has filed an appeal after he lost a challenge to his compensation determination, 12 years after the case settled.
A group of class actions against healthcare providers in Victoria that allegedly failed to pay junior doctors for overtime have settled for $175 million.
Victorian healthcare providers facing class actions on behalf of junior doctors have turned to one law firm to lead their defence. And that firm might be about to get a lot busier.
The plaintiff in an unsuccessful class action against Bayer over its Essure contraceptive device wants to see whether she can avoid paying costs in the case before deciding on whether to appeal the loss.
Pharmaceutical giant Lundbeck has resolved its battle with Novartis unit Sandoz over top-selling drug Lexapro, a battle that has raged for years and across multiple courts.
A class action against Sydney doctor Daniel Lanzer and several of his associates over alleged botched cosmetic surgeries wants to drop its claims against one doctor, but other defendants have taken issue.
US drug maker Allergan may defend a class action over recalled textured breast implants by arguing its knowledge of the alleged defects was limited by the state of scientific knowledge at the time the products were made.